Clinical Trial Update: RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of rifalazil in Chlamydia pneumoniae seropositive patients with a history of atherosclerotic disease, evaluating effects in corona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disease
• Coronary Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• Rifalazil (rifalazil)

Snippet

Sponsor: ActivBiotics | Conditions: Coronary Artery Disease, Cerebrovascular Disease | Phase 2 | Status: UNKNOWN